|
1
|
Ishihara S, Horiguchi A, Miyakawa S, Endo
I, Miyazaki M and Takada T: Biliary tract cancer registry in Japan
from 2008 to 2013. J Hepatobiliary Pancreat Sci. 23:149–157. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wakai T, Shirai Y, Sakata J, Maruyama T,
Ohashi T, Korira PV, Ajioka Y and Hatakeyama K: Clinicopathological
features of benign biliary strictures masquerading as biliary
malignancy. Am Surg. 78:1388–1391. 2012.PubMed/NCBI
|
|
3
|
Burnett AS, Calvert TJ and Chokshi RJ:
Sensitivity of endoscopic retrograde cholangiopancreatography
standard cytology: 10-y review of the literature. J Surg Res.
184:304–311. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Navaneethan U, Njei B, Lourdusamy V,
Konjeti R, Vargo JJ and Parsi MA: Comparative effectiveness of
biliary brush cytology and intraductal biopsy for detection of
malignant biliary strictures: A systematic review and
meta-analysis. Gastrointest Endosc. 81:168–176. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yonezawa S, Higashi M, Yamada N, Yokoyama
S and Goto M: Significance of mucin expression in pancreatobiliary
neoplasms. J Hepatobiliary Pancreat Sci. 17:108–124. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moschovis D, Bamias G and Delladetsima I:
Mucins in neoplasms of pancreas, ampulla of Vater and biliary
system. World J Gastrointest Oncol. 8:725–734. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Inagaki Y, Xu H, Nakata M, Seyama Y,
Hasegawa K, Sugawara Y, Tang W and Kokudo N: Clinicopathology of
sialomucin: MUC1, particularly KL-6 mucin, in gastrointestinal,
hepatic and pancreatic cancers. Biosci Trends. 3:220–232.
2009.PubMed/NCBI
|
|
8
|
Tang W, Inagaki Y, Kokudo N, Guo Q, Seyama
Y, Nakata M, Imamura H, Sano K, Sugawara Y and Makuuchi M: KL-6
mucin expression in carcinoma of the ampulla of Vater: Association
with cancer progression. World J Gastroenterol. 11:5450–5454. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu HL, Inagaki Y, Seyama Y, Sugawara Y,
Kokudo N, Nakata M, Wang FS and Tang W: Expression of KL-6 mucin, a
human MUC1 mucin, in intrahepatic cholangiocarcinoma and its
potential involvement in tumor cell adhesion and invasion. Life
Sci. 85:395–400. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang W, Guo Q, Qu X, Inagaki Y, Seyama Y,
Midorikawa Y, Gai R, Kokudo N, Sugawara Y, Nakata M and Makuuchi M:
KL-6 mucin is a useful immunohistochemical marker for
cholangiocarcinoma. Oncol Rep. 17:737–741. 2007.PubMed/NCBI
|
|
11
|
Xu H, Inagaki Y, Tang W, Guo Q, Wang F,
Seyama Y, Midorikawa Y, Gai R, Kokudo N, Sugawara Y, et al:
Elevation of serum KL-6 mucin levels in patients with
cholangiocarcinoma. Hepatogastroenterology. 55:2000–2004.
2008.PubMed/NCBI
|
|
12
|
Matsumoto K, Takeda Y, Harada K, Onoyama
T, Kawata S, Horie Y, Sakamoto T, Ueki M, Miura N and Murawaki Y:
Clinical impact of the KL-6 concentration of pancreatic juice for
diagnosing pancreatic masses. Biomed Res Int. 2015:5283042015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cotton PB, Garrow DA, Gallagher J and
Romagnuolo J: Risk factors for complications after ERCP: A
multivariate analysis of 11,497 procedures over 12 years.
Gastrointest Endosc. 70:80–88. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Andriulli A, Loperfido S, Napolitano G,
Niro G, Valvano MR, Spirito F, Pilotto A and Forlano R: Incidence
rates of post-ERCP complications: A systematic survey of
prospective studies. Am J Gastroenterol. 102:1781–1788. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sadeghi A, Mohamadnejad M, Islami F,
Keshtkar A, Biglari M, Malekzadeh R and Eloubeidi MA: Diagnostic
yield of EUS-guided FNA for malignant biliary stricture: A
systematic review and meta-analysis. Gastrointest Endosc.
83:290–8.e1. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Weilert F, Bhat YM, Binmoeller KF, Kane S,
Jaffee IM, Shaw RE, Cameron R, Hashimoto Y and Shah JN: EUS-FNA is
superior to ERCP-based tissue sampling in suspected malignant
biliary obstruction: Results of a prospective, single-blind,
comparative study. Gastrointest Endosc. 80:97–104. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
De Moura DT, Moura EG, Bernardo WM, De
Moura ET, Baracat FI, Kondo A, Matuguma SE and Artifon EL:
Endoscopic retrograde cholangiopancreatography versus endoscopic
ultrasound for tissue diagnosis of malignant biliary stricture:
Systematic review and meta-analysis. Endosc Ultrasound. Nov
8–2016.(Epub ahead of print).
|
|
18
|
Heimbach JK, Sanchez W, Rosen CB and Gores
GJ: Trans-peritoneal fine needle aspiration biopsy of hilar
cholangiocarcinoma is associated with disease dissemination.
HPB(Oxford). 13:356–360. 2011.PubMed/NCBI
|
|
19
|
Bonella F, Long X, Ohshimo S, Horimasu Y,
Griese M, Guzman J, Kohno N and Costabel U: MUC1 gene polymorphisms
are associated with serum KL-6 levels and pulmonary dysfunction in
pulmonary alveolar proteinosis. Orphanet J Rare Dis. 11:482016.
View Article : Google Scholar : PubMed/NCBI
|
